TORONTO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SLHGF) (“Skylight Health” or the “Company”), a healthcare platform combining technology and analytics...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 18...
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at...
NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry...
TORONTO, May 6, 2011 (GLOBE NEWSWIRE) -- Shield Gold Inc. (TSX-V:SHG) (the "Corporation") is pleased to announce that it has completed its non-brokered private placement (the "Offering...
TORONTO, April 7, 2011 (GLOBE NEWSWIRE) -- Shield Gold Inc. (the "Corporation") (TSX-V:SHG) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") of...
TORONTO, March 31, 2011 (GLOBE NEWSWIRE) -- Shield Gold Inc. (TSX-V:SHG) is pleased to announce the closing on March 30, 2011, of a non-brokered flow-through private placement with the...
TORONTO, Feb. 10, 2011 (GLOBE NEWSWIRE) -- Shield Gold Inc. ("Shield" or the "Company") (TSX-V:SHG) is pleased to announce that the report on its 2010 exploration program on the Summit-Gaber and...
TORONTO, Oct. 26, 2010 (GLOBE NEWSWIRE) -- Shield Gold Inc. ("Shield" or the "Company") (TSX-V:SHG) is pleased to report that the field work for its 2010 exploration program on the Summit-Gaber...
TORONTO, Oct. 5, 2010 (GLOBE NEWSWIRE) -- Shield Gold Inc. (TSX-V:SHG-P) (TSX-V:SHG) ("Shield" or the "Company") is pleased to report that its 2010 field exploration program on the Summit-Gaber...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 6.8 | 6.8 | 6.8 | 0 | 0 | CS |
4 | 0 | 0 | 6.8 | 6.8 | 6.8 | 0 | 0 | CS |
12 | 0 | 0 | 6.8 | 6.8 | 6.8 | 0 | 0 | CS |
26 | 0 | 0 | 6.8 | 6.8 | 6.8 | 0 | 0 | CS |
52 | 0 | 0 | 6.8 | 6.8 | 6.8 | 0 | 0 | CS |
156 | 0 | 0 | 6.8 | 6.8 | 6.8 | 0 | 0 | CS |
260 | 5.35 | 368.965517241 | 1.45 | 7.4 | 0.85 | 103991 | 1.43605977 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales